Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iShares US Real Estate ETF
IYR
|
+$1B |
| 2 |
Tesla
TSLA
|
+$697M |
| 3 |
Microsoft
MSFT
|
+$447M |
| 4 |
Accenture
ACN
|
+$439M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$421M |
Top Sells
| 1 |
CRH
CRH
|
+$2.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.01B |
| 3 |
Texas Instruments
TXN
|
+$1.97B |
| 4 |
Starbucks
SBUX
|
+$1.61B |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$1.07B |
Sector Composition
| 1 | Technology | 32.41% |
| 2 | Financials | 11.84% |
| 3 | Consumer Discretionary | 10.72% |
| 4 | Healthcare | 9.02% |
| 5 | Communication Services | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Chegg
CHGG
$167M
| $407K | ﹤0.01% |
230,012
+155,662
| +209% | +$275K |
|
3002
Home Bancorp
HBCP
$433M
| $407K | ﹤0.01% |
9,142
+6,785
| +288% | +$302K |
|
|
AAN
3003
DELISTED
The Aaron's Company, Inc.
AAN
| $403K | ﹤0.01% |
40,542
+29,882
| +280% | +$297K |
|
3004
ADC Therapeutics
ADCT
$372M
| $402K | ﹤0.01% |
127,739
+93,890
| +277% | +$295K |
|
3005
Avita Medical
RCEL
$123M
| $402K | ﹤0.01% |
37,503
+28,979
| +340% | +$311K |
|
3006
Biomea Fusion
BMEA
$115M
| $401K | ﹤0.01% |
39,620
+24,162
| +156% | +$245K |
|
|
INZY
3007
DELISTED
Inozyme Pharma
INZY
| $401K | ﹤0.01% |
76,730
+55,497
| +261% | +$290K |
|
3008
Global Water Resources
GWRS
$271M
| $400K | ﹤0.01% |
31,663
+14,936
| +89% | +$189K |
|
3009
Zevra Therapeutics
ZVRA
$435M
| $399K | ﹤0.01% |
57,599
+42,926
| +293% | +$297K |
|
3010
Fidelity D&D Bancorp
FDBC
$267M
| $398K | ﹤0.01% |
8,061
+5,082
| +171% | +$251K |
|
3011
Ranger Energy Services
RNGR
$298M
| $398K | ﹤0.01% |
33,404
+15,139
| +83% | +$180K |
|
3012
West Bancorporation
WTBA
$344M
| $398K | ﹤0.01% |
20,977
+15,615
| +291% | +$296K |
|
3013
Chunghwa Telecom
CHT
$34.8B
| $397K | ﹤0.01% |
+10,000
| New | +$397K |
|
|
BHR
3014
Braemar Hotels & Resorts
BHR
$203M
| $394K | ﹤0.01% |
127,641
+45,284
| +55% | +$140K |
|
3015
The Honest Company
HNST
$447M
| $394K | ﹤0.01% |
110,386
+82,713
| +299% | +$295K |
|
3016
Freedom Holding
FRHC
$10.1B
| $393K | ﹤0.01% |
4,144
+3,840
| +1,263% | +$364K |
|
3017
Larimar Therapeutics
LRMR
$336M
| $393K | ﹤0.01% |
60,032
+45,781
| +321% | +$300K |
|
|
THRD
3018
DELISTED
Third Harmonic Bio
THRD
| $393K | ﹤0.01% |
29,012
+18,710
| +182% | +$253K |
|
3019
Viemed Healthcare
VMD
$263M
| $392K | ﹤0.01% |
53,439
+41,358
| +342% | +$303K |
|
3020
Security National Financial
SNFCA
$237M
| $391K | ﹤0.01% |
44,610
+8,137
| +22% | +$71.3K |
|
3021
Velocity Financial
VEL
$720M
| $391K | ﹤0.01% |
19,916
+11,583
| +139% | +$227K |
|
|
LENZ
3022
LENZ Therapeutics
LENZ
$1.18B
| $391K | ﹤0.01% |
16,463
+12,051
| +273% | +$286K |
|
|
NOA
3023
North American Construction
NOA
$399M
| $390K | ﹤0.01% |
20,867
+6,774
| +48% | +$127K |
|
3024
Frontier Group Holdings
ULCC
$1.18B
| $389K | ﹤0.01% |
72,866
+57,642
| +379% | +$308K |
|
3025
American Vanguard Corp
AVD
$160M
| $388K | ﹤0.01% |
73,112
+27,229
| +59% | +$145K |
|